HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Rhabdoid Tumor

Rhabdoid Tumor

Rhabdoid tumors are aggressive and rare cancers primarily affecting infants and young children. They most commonly occur in the kidneys, but can also develop in the brain, spinal cord, or other soft tissues. These tumors are characterized by their fast growth and tendency to spread to other parts of the body. Despite advances in cancer research, treatment options for rhabdoid tumors remain limited, and they often have poor outcomes.

Researchers are actively studying the genetic and molecular mechanisms underlying rhabdoid tumors to develop more effective treatments. Recent studies have identified specific genetic mutations associated with these tumors, providing potential targets for precision therapies. Immunotherapy, which harnesses the body's immune system to fight cancer, is also being explored as a promising treatment approach. Continued research efforts are crucial to improving outcomes for patients with rhabdoid tumors and advancing our understanding of this complex disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp